Levetiracetam 81033-0013-50
- Manufacturer
- Kesin Pharma Corporation
- Dosage Form
- Solution
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 18, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA079120
Need to source Levetiracetam? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Levetiracetam | 100 mg/mL |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
81033-0013-50Selected50 CUP, UNIT-DOSE in 1 CARTON (81033-013-50) / 5 mL in 1 CUP, UNIT-DOSE (81033-013-05)